background-splash

Tag: Autolus

Autolus received FDA approval for its innovative CAR-T oncology treatment in 2023, following positive phase two trial data. Founded by top-tier venture capitalists, the company has come a long way in just ten years, and its CAR-T therapies could reshape cancer treatment.

Never miss a new episode 💌

Trusted by 350+ professionals from top companies like Argenx, BioNTech, or Genmab. No spam, no noise.

Watch & Subscribe